Clinical & Diagnostic

Rebuilding the Drug Repurposing Pipeline with Better Data

How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development. ...

Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board

Renowned oncology expert joins to support advancement of next-generation cancer diagnostics and therapeutics....

NeoCast™ Liquid Embolic Shows Promise as Pain-Free Treatment for Chronic Subdural Hematoma

Next-generation embolic technology enables rapid resorption and improved patient comfort in minimally invasive neurointervention...

Erbe Launches FiAPC® plus to Elevate Argon Plasma Coagulation Precision

Next-Generation Technology Enhances Control, Safety, and Efficiency in Flexible Endoscopic Procedures ...

VISIE Executes First Pin-Free Knee Bone Cuts Using Spatial Computing

Breakthrough Procedure Marks a Milestone in Orthopedic Surgery with Pin-Free Navigation and Augmented Reality-Driven Precision...

U.S. FDA Grants Breakthrough Device Designation to Artera’s AI-Powered Prostate Cancer Decision Support Tool

Innovative software platform leverages artificial intelligence to personalize therapy decisions and improve clinical outcomes for prostate cancer patients....

Mann Eye Institute Unveils Pioneering Treatment for Dry AMD

New Therapeutic Breakthrough Offers Hope for Patients with Geographic Atrophy, the Advanced Form of Dry Age-Related Macular Degeneration...

Empatica Launches EmbraceMini: World’s Smallest Actigraphy Wearable for Clinical Trials

Designed for long-term monitoring and patient comfort, EmbraceMini sets a new benchmark in wearable technology for decentralized and real-world evidence studies....

MolecuLight Unveils Advanced Multimodal Imaging with Thermal Capabilities at St. Louis Wound & Vascular Symposium

New imaging innovation enhances wound assessment by combining fluorescence and thermal data for improved diagnostic precision and patient care ...

Hera Biotech Acquires HeraFem to Advance High-Sensitivity Cervical Cancer Diagnostics

Acquisition boosts Hera’s women’s health platform with 91% sensitivity point-of-care test, strengthening early cervical cancer detection capabilities....